Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Application Number 16213954

16213954
Not Appealed
Patent NumberUS 10266594 B1
Publication NumberUS 20190100589 A1
Filled DateDec 7, 2018
Priority DateMay 15, 2012
Inventor/ApplicantsAshok K. Gupta
Xi-Tao Wang
John P. Cogswell
Maria Jure-Kunkel
Stacie M. Goldberg
Jon M. Wigginton
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Assignments
Bristol Myers Squibb
Current
Bristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.